Anti-fungal Drugs Market
                     Title : Anti-fungal Drugs Market to Exhibit 3.3% CAGR till 2027
Anti-fungal Drugs Market to Reach USD 13.17 Billion by 2027;Increasing Number of  
Infectious Skin Disorders to Aid Growth
Description : Anti-fungal Drugs Market to Gain Significant Share from Merck & Co. Inc. and  
Astellas Pharma Inc. on Account of the Popularity of their Products
Content :
The global anti-fungal drugs market size is likely to reach USD 13.17 billion by 2027 on  
account of the increasing prevalence of skin infections worldwide. Mycosis or fungal  
infection is a skin disease caused by a group of spore-producing organisms living and feeding  
on the human skin. When untreated, they lead to skin issues such as rashes, athlete’s foot,  
yeast infection, ringworm, nail fungus, bumps, and others. According to a recently published  
report by Fortune Business Insights™ titled, “Anti-Fungal Drugs Market Size, Share &  
Industry Analysis, By Drug Type (Echinocandins, Azoles, Polyenes, and Allylamines), By  
Indication (Dermatophytosis, Aspergillosis, Candidiasis, and Others), By Route of  
Administration (Oral, Topical, and Parenteral), By Distribution Channel (Hospital  
Pharmacies, Retails Pharmacies & Stores, and Others), and Regional Forecast, 2020-2027,”  
the market value was USD 10.24 billion in 2019, and will exhibit a CAGR of 3.3% between  
2020 and 2027.
An Overview of the Impact of COVID-19 on this Market:
The emergence of COVID-19 has brought the world to a standstill. We understand that this  
health crisis has brought an unprecedented impact on businesses across industries.
However, this too shall pass. Rising support from governments and several companies can  
help in the fight against this highly contagious disease. There are some industries that are  
struggling and some are thriving. Overall, almost every sector is anticipated to be impacted  
by the pandemic.
We are taking continuous efforts to help your business sustain and grow during COVID-19  
pandemics. Based on our experience and expertise, we will offer you an impact analysis of  
corona virus outbreak across industries to help you prepare for the future.
Click here to get the short-term and long-term impact of COVID-19 on this [Market].
For More Information :
https://www.fortunebusinessinsights.com/industry-reports/antifungal-drugs-market-  
101188
Report Highlights:
• A 360-degree overview of the market.
• Factors propelling, repelling, challenging, and offering lucrative growth opportunities  
to the market.
• Detailed analysis of the table of segmentation.
• List of market manufacturers and the key strategies adopted by them.
• Significant Industry developments and other interesting insights into the market.
• Other anti-fungal drugs market trends.
Market Drivers
Increasing Cases of Fungal Infections – Major Growth Driver
Various factors are responsible for the anti-fungal drugs market growth. These include the  
increasing number of bacterial skin infections and other skin issues. Besides this, a rise in the  
number of cancer cases and the growth of hematopoietic stem cell transplantation have led  
to the increasing incidence of nosocomial infections that will further propel the market in  the 
years to follow.
On the contrary, arise in the availability of generic drugs among other expensive drugs for  
treating fungal infections may pose a major hindrance to the overall market. This, coupled  
with the strict rules imposed by the government on patent expiry and use of counterfeit  
drugs are expected to hamper the market. Additionally, the use of adverse drugs may result  
in hypokalemia, bone marrow suppression, nephrotoxicity, and others, thus posing major  
challenges to the market in the coming years.
Competitive Landscape
Merck & Co. Inc. and Astellas Pharma Inc. Holding Dominant Positions in Market
The global antifungal drugs market is dominated by companies such as Astellas Pharma Inc.  
and Merck & Co. Inc. because of their diverse portfolio. The success and popularity of  
products such as Mycamine and AmBisome by Astellas Pharma on the one side and  
Noxafilwilland Cancidas on the other will help these players attract high revenue in the  
coming years. Some of the vendors are also engaging inmergers and acquisitions, contracts  
and agreements, partnerships, and joint ventures to gain a competitive edge in the market  
during the forecast period.
More Trending Topics from Fortune Business Insights:
Europe Compression Bandages Market Share, Growth, Sales and Drivers Analysis Research  
Report 2026
Europe Compression Bandages Market to Witness a Healthy CAGR of 5.2%; Advent of  
Efficient Pressure Bandages to Provide Impetus, says Fortune Business Insights